Midostaurin in addition to intensive chemotherapy in acute myeloid leukemia with t(8;21) and <i>KIT</i> and/or <i>FLT3-</i>ITD mutations: results of the SAL MIDOKIT trial
Ruhnke, Leo, Röllig, Christoph, Herold, Sylvia, Sauer, Tim, Brandts, Christian H, Steffen, Björn, Schäfer-Eckart, Kerstin, Krause, Stefan W, Hänel, Mathias, Reichle, Albrecht, Scholl, Sebastian, Neubauer, Andreas, Mikesch, Jan-Henrik, Schetelig, Johannes, Stölzel, Friedrich, Kramer, Michael, Haake, Annett, Frimmel, Julia, Krämer, Alwin, Schlenk, Richard, Platzbecker, Uwe, Serve, Hubert, Baldus, Claudia D, Müller-Tidow, Carsten, Aust, Daniela, Bornhäuser, Martin, Ehninger, Gerhard and Thiede, Christian (2023) Midostaurin in addition to intensive chemotherapy in acute myeloid leukemia with t(8;21) and <i>KIT</i> and/or <i>FLT3-</i>ITD mutations: results of the SAL MIDOKIT trial. Haematologica.Date of publication of this fulltext: 18 Mar 2025 10:10
Article
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Haematologica | ||||
| Publisher: | FERRATA STORTI FOUNDATION | ||||
|---|---|---|---|---|---|
| Place of Publication: | PAVIA | ||||
| Date | 2023 | ||||
| Institutions | Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie) | ||||
| Identification Number |
| ||||
| Keywords | INV(16); CANCER; ADULTS | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 76194 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric